SCHEMBL3822928

SCHEMBL3822928

COC(=O)c1nc(C)c(CN)o1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.36
LOXL2 Q9Y4K0 2/20 0.36
VDR P11473 5/20 0.35
KDM4E B2RXH2 4/20 0.35
KMT2A Q03164 1/20 0.35
ALDH1A1 P00352 5/20 0.34
MAPK1 P28482 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 3/20 0.33
HSD17B10 Q99714 2/20 0.33
FBP1 P09467 2/20 0.33
ESR1 P03372 1/20 0.33
THRA P10827 1/20 0.33
THRB P10828 1/20 0.33
RXRA P19793 1/20 0.33
PPARG P37231 1/20 0.33
PPARD Q03181 1/20 0.33
PPARA Q07869 1/20 0.33
ESR2 Q92731 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3824174 0.83 ALDH1A1 (0.37) NPSR1VDRKDM4EKMT2AALDH1A1
SCHEMBL3829761 0.75 VDR (0.36) NPSR1VDRALDH1A1LMNAESR1
SCHEMBL3822551 0.75 TSHR (0.46) KDM4EKMT2AALDH1A1LMNAHPGD
SCHEMBL3822923 0.74 ALDH1A1 (0.41) NPSR1KDM4EKMT2AALDH1A1LMNA
SCHEMBL28469708 0.73 NPSR1 (0.40) NPSR1VDRKDM4EKMT2AALDH1A1
SCHEMBL3586970 0.72 NPSR1 (0.38) NPSR1LOXL2KDM4EALDH1A1MAPK1
SCHEMBL3821090 0.70 DPP4 (0.42) LOXL2KDM4EKMT2AALDH1A1LMNA
Hydrochloric Acid SCHEMBL3829383 0.69 ELANE (0.43) NPSR1KDM4EKMT2AALDH1A1HSD17B10
SCHEMBL4982420 0.68
Hydrochloric Acid SCHEMBL17185351 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2096111-A1 PYRAZOLES AND USE THEREOF AS DRUGS Japan Tobacco Inc. (JP) 2009-09-02 EP claimed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US claimed
EP-2096111-A1 PYRAZOLES AND USE THEREOF AS DRUGS Japan Tobacco Inc. (JP) 2009-09-02 EP disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF PYGL, GYS2, G6PC1 NPSR1 3657/4885LOXL2 3992/4885VDR 2038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.